Depo-Provera does not increase fracture risk.

Results from a new study published in the March issue of Obstetrics and Gynaecology demonstrate that the use of depot medroxyprogesterone acetate (DMPA) does not appear to increase fracture risk. Whilst the use of DMPA reduces serum oestrogen levels and is associated with significant loss of bone mineral density (BMD), this study shows that it […]

Read More…

Journal Online First

The following Online Firsts have been published Does a full bladder assist insertion of intrauterine contraception?: a randomised trial (Cameron, Glasier, Cooper,  Johnstone) Cameron and colleagues set out to answer a simple question: does a full bladder assist insertion of intrauterine contraception? In the world of assisted conception a full bladder had been shown to […]

Read More…

Press Releases: Risk of Unwanted Pregnancies with Morning After Pill Conscience Clause & Cuts to services set to cost UK £136.7 billion

Risk of Unwanted Pregnancies with Morning After Pill Conscience Clause This article is published in the Journal of Medical Ethics today – “The Fox and the grapes: an Anglo-Irish perspective on conscientious objection to the supply of emergency hormonal contraception without prescription” Conscience clauses, which allow pharmacists to opt out of providing the “morning after […]

Read More…

SRH News

Education for Choice hightlights misleading pregnancy counselling Education for Choice support young people’s right to informed choice on abortion. They report that Feminist Action Cambridge held a demo in Cambridge city centre to raise awareness of local ‘crisis pregnancy centres’ which they feel are ‘using emotionally manipulative techniques’ and misinformation ‘in order to increase the […]

Read More…

Some ‘Online Firsts’ and News

The following papers have been published at http://jfprhc.bmj.com/content/early/recent The financial costs to patients of diagnosing and excluding ectopic pregnancy (Unger et al) In their article, Unger and his colleagues in Edinburgh report on their assessment of an area of patient experience that is not often considered when assessing medical interventions. The financial impact on patients’ […]

Read More…

Drugs – What’s in a name?

Branded, generics or branded generics? Do you know the difference? When a branded, or proprietary, drug comes ‘off patent’ it is common for other companies to apply for marketing authorisation and we are, increasingly, seeing this in sexual health. This can be for generic versions or for branded generics. Branded generics are simply generic equivalent […]

Read More…

The Journal – October Issue

Highlights from this issue include: The effects of childhood sexual abuse on women’s lives and their attitudes to cervical screening This commentary by Sarah Kelly is the and available free. Barriers to cervical screening in women who have experienced sexual abuse: an exploratory study This   article by Cadman et al. explores the barriers that […]

Read More…

FIAPAC and ESC Conference Reminders

    There is still time to register for FIAPAC 2012 in Edinburgh – October 19th-20th – Unwanted Pregnancy: A fact of life   ESC – Global Conference – Call for Papers   The First global conference on contraception, reproductive and sexual health will be held in Copenhagen from 22-25th May 2013. The closing date […]

Read More…

Online First – August

The following papers have been published this month at http://jfprhc.bmj.com/content/early/recent More than poverty: disruptive events among women having abortions in the USA (Jones) We are all aware that poverty is associated with abortion but how many of us knew that bad (or disruptive) life events also play a major role? The research by Jones et […]

Read More…